Search bioRxiv⌕ Search

Biology subjects

Cooney, C.

Publications and source records attributed to Cooney, C..

4 recordsLinked to original sources

PlumageParts: A fine-grained avian plumage segmentation dataset and benchmark for ecological image analysis

Fine-grained localisation of plumage regions is a prerequisite for computational analyses of avian colouration, patterning and visual traits in ecological and evolutionary research. Progress is limited by the scarcity of image resources with annotations aligned to biologically meaningful anatomical units: existing avian benchmarks provide either landmark points or coarse part categories that do not capture ornithologically defined plumage regions. We present a curated dataset of 4,705 bird images annotated for nine plumage regions: head, throat, breast, belly, vent, back, coverts, remiges and tail. Spanning 39 avian orders and 222 families, the dataset provides a taxonomically broad resource for fine-grained avian image analysis. The dataset was built through an iterative model-assisted annotation workflow, in which model predictions were reviewed and corrected rather than drawn from scratch, improving the efficiency of region-level annotation. We benchmark classical segmentation architectures, SAM-based models and self-supervised foundation-model encoders on this task. A frozen DINOv3 encoder with a lightweight decoder achieved the highest performance on the held-out test set, reaching 84.01% mean Intersection over Union while requiring substantially less memory than end-to-end fine-tuning. The model generalised to external avian benchmarks, including the bird subset of PartImageNet and CUB-200-2011, and achieved competitive performance on the full PartImageNet part-segmentation benchmark, which includes diverse animal taxa. We provide a modular detect-track-segment pipeline as a proof-of-concept extension to video data. Together, these results show that anatomically grounded avian annotations can serve both as a resource for plumage phenotyping and as a benchmark for efficient, transferable biological part segmentation. Author SummaryBirds vary enormously in colour and pattern, but studying this variation at large scales requires more than identifying the bird in a photograph. Researchers often need to know where each colour or pattern occurs on the body, such as on the head, throat, breast, wing or tail. We created PlumageParts to make this kind of region-level analysis easier. The dataset contains 4,705 bird images annotated into nine biologically meaningful plumage regions, covering a wide range of bird families and orders. To build the dataset efficiently, we used a model-assisted workflow in which computer-generated masks were checked and corrected by researchers rather than drawn entirely by hand. We then tested several image-segmentation approaches and found that a frozen self-supervised vision model, combined with a lightweight decoder, provided accurate plumage-region predictions while requiring relatively modest computing resources. The same approach also performed well on a broader animal part-segmentation benchmark, suggesting that it may be useful beyond birds when suitable annotations are available. By releasing the annotations, code and trained model, we aim to support future studies of bird plumage and biologically meaningful image segmentation.

ecology↗

Transgene Expression Kinetics and Replication Potential of Recombinant Adenovirus Serotype 4 in a Mouse Model and its Use as a Herpes Simplex Virus Vaccine

Human adenovirus serotype 4 (Ad4) is used as a replication-competent oral vaccine that safely and effectively prevents Ad4 respiratory illness in US military personnel. Recombinant Ad4 vaccine candidates elicit mucosal and systemic immune responses against respiratory viruses in hamsters, nonhuman primates, and humans. Although evaluation of Ad4 vaccine candidates in mice would be extremely useful given the large number of immunologic tools available, this has been limited by concerns about a lack of viral replication in these animals. Here we generated recombinant Ad4 vectors that express either luciferase (Ad4-Luc) or herpes simplex virus type 2 (HSV-2) glycoprotein D (Ad4-gD2) to identify transgene expression kinetics, the presence of Ad4 vector replication, and HSV-2 immune responses and protection against HSV-2 infection. Local luciferase activity was observed from 7 hours to 20 days after intranasal inoculation of BALB/c and humanized mice. Subsequent inoculations with Ad4-Luc showed reduced luciferase expression in BALB/c mice, but robust expression in humanized mice, suggesting an immune response to the vector in wild-type mice. Ad4 DNA, but not luciferase activity, was reduced in the lungs of BALB/c mice treated with cidofovir before inoculation with Ad4, implying that Ad4 replicated, albeit at a low level, in the lungs. Intranasal vaccination of mice with Ad4-gD2 resulted in HSV-2 neutralizing antibody in the serum, and after HSV-2 intravaginal challenge reduced disease scores, increased survival, and reduced shedding. Overall, the BALB/c mouse model is semi-permissive to Ad4 mucosal infection, but transgene expression is sufficient for the study of Ad4-based vaccine candidates. ImportanceMucosal surfaces serve as the primary site of infection and shedding for many viral pathogens. Immune responses at mucosal sites provide protection, but few mucosal vaccines are licensed. The oral replication-competent adenovirus serotype 4 (Ad4) vaccine is used to prevent respiratory illness in military recruits, has an extraordinary record of safety and efficacy and has been tested as a recombinant platform for other viruses. Further development of this vaccine platform has been partially hindered by the perceived inability to evaluate vaccine candidates in mice. Here we characterize recombinant Ad4 transgene expression kinetics and viral replication after inoculation at various sites and show protection against herpes simplex virus type 2 (HSV-2) genital disease in mice after intranasal vaccination. We show that Ad4 can induce protective efficacy, even in a semi-permissive mouse model, suggesting this is a promising vector for HSV-2 and potentially other viral pathogens.

immunology↗

Intranasal Replicating Adenovirus type 4-SARS-CoV-2 Recombinants Induce Superior Immune Response Durability and Efficacy in Preclinical Testing Compared to Standard Intramuscular Vaccines

The portfolio of next generation COVID-19 vaccines would benefit from candidates that induce durable systemic and mucosal immune responses that would lessen person-to-person transmission. We constructed an intranasal (IN) replication-competent adenovirus type 4 recombinant platform to express SARS-CoV-2 Spike variants (Ad4-S) and assessed immunogenicity and efficacy in the Syrian hamster model. Although both IN Ad4-S and intramuscular (IM) vaccines (Ad26.CoV2.S and mRNA-1273) induced serum binding antibodies, only Ad4-S induced a robust mucosal response in the nasal cavity. IN Ad4-S vaccination induced serum neutralizing titers equivalent to or greater than IM vaccination but more durable up to 6 months. Upon challenge, IN immunization also resulted in less weight loss, greater breadth and durability of restriction of viral replication, and less lung pathology than IM immunization up to 268 days after immunization. These data support the potential of the IN Ad4 vaccine platform to reduce transmission of SARS-CoV-2 and other respiratory viruses with pandemic potential.

immunology↗

Immune checkpoint inhibitors amplify type 2 immune mediated repair bypro-regenerative scaffolds

Extracellular matrix (ECM) scaffolds induce type 2 immunity to promote repair. Here, we show that immune cells recruited to ECM-treated murine muscle injuries and clinical soft tissue defects express immune checkpoints. Specifically, TH2 cells and regulatory T cells (Tregs) increase LAG3 expression, while macrophages express PDL2. TCR analysis and a triple-reporter strain for interleukin (IL)-13 and Treg fate-mapping suggest that Tregs in ECM-treated wounds transition into TH2-like exTregs that express LAG3. Immune checkpoint inhibition (ICI) significantly stimulated type 2 immunity in ECM-treated wounds, including increased TH2 cells, Treg transition to TH2-like exTregs, and pro-regenerative macrophages. Moreover, ICI enhanced muscle repair and reduced fibrosis in ECM-treated wounds. Collectively, these findings show Treg/TH2 plasticity in wound healing and introduce a novel ICI application to enhance immune-mediated regeneration.

bioengineering↗